BRNS
Barinthus Biotherapeutics
BRNS
BRNS
14 hedge funds and large institutions have $9.02M invested in Barinthus Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 15 → 14 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MGP
1
M&G plc
London,
United Kingdom
| $5.2M |
|
|||
|
AI
2
Alphabet Inc
Mountain View,
California
| $1.41M |
|
|||
|
HH
3
HSG Holding
Na,
Hong Kong
| $1.32M |
|
|||
|
DF
4
DC Funds
Mclean,
Virginia
| $597K |
|
|||
5
Baird Financial Group
Milwaukee,
Wisconsin
| $179K |
|
|||
|
JHU
6
Johns Hopkins University
Baltimore,
Maryland
| $114K |
|
|||
|
GS
7
Gilead Sciences
Foster City,
California
| $92.5K |
|
|||
8
HighTower Advisors
Chicago,
Illinois
| $34.8K |
|
|||
9
Renaissance Technologies
New York
| $33.8K |
|
|||
10
Citadel Advisors
Miami,
Florida
| $14.8K |
|
|||
11
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $14K |
|
|||
12
Geode Capital Management
Boston,
Massachusetts
| $10.5K |
|
|||
13
Morgan Stanley
New York
| $4.51K |
|
|||
|
NECFA
14
New England Capital Financial Advisors
Meriden,
Connecticut
| $42 |
|